NCT05969171 2025-07-30A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic CancerFudan UniversityPhase 2 Recruiting65 enrolled